Global Neuropathic Pain Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global neuropathy pain market over the forecast period due to increasing research and developments activities for neuropathy drugs increase global neuropathic pain market. For instance, in September 2021, Biogen, a U.S.-based biotechnology company, announced positive results of Vixotrigine from phase 2. Vixotrigine a non-opioid oral pain drug evaluate for the treatment of chronic painful neuropathy.
Neuropathic Pain Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients